Reliable identification of small cell lung cancer in cytological specimens by immunocytology

Onkologie

Volumn 30, Issue 6, 2007, Pages 311-315

  Metzgeroth, G ^a   Mantz, C ^a   Kuhn, C ^a   Schultheis, B ^a   Hehlmann, R ^a   Hastka, J ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HEA125; Immunocytology; Lung cancer, small cell; MOC 1

Indexed keywords

CYTOKERATIN ANTIBODY; MONOCLONAL ANTIBODY;

ARTICLE; BRONCHUS CARCINOID; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; SMEAR; SQUAMOUS EPITHELIUM; TISSUE SECTION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, CD56; CARCINOID TUMOR; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LUNG; LUNG NEOPLASMS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249940725     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102145     Document Type: Article

References (35)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, et al.: World Health Organization International Histological Classification of Tumors. Histological Typing of Lung and Pleural Tumours, ed 3. Berlin, Springer, 1999.
2. Dragan AM, Simu G, Vaida T: The histopathological and immunohistochemical diagnosis in small cell lung carcinoma. Rom J Morphol Embryol 1999;45:91-95.
3. Yesner R: Small cell tumors of the lung. Am J Surg Pathol 1983;7:775-785.
4. Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ, The H: Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 1989;7:1614-1620.
5. Broers JL, Rot MK, Oostendorp T, Huysmans A, Wagenaar SS, Wiersma-van Tilburg AJ, Vooijs GP, Ramaekers FC: Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res 1987;47:3225-3234.
6. de Leij L, Poppema S, Nulend JK, ter Haar A, Schwander E, Ebbens F, Postmus PE, The TH: Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res 1985;45:2192-2200.
7. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985;45:2913-2923.
8. Lehto VP, Stenman S, Miettinen M, Dahl D, Virtanen I: Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol 1983;110:113-118.
9. Leube RE, Wiedenmann B, Franke WW: Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression. Klin Wochenschr 1988;66(suppl 11):80-86.
10. Lyda MH, Weiss LM: Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol 2000;31:980-987.
11. Sheppard MN, Corrin B, Bennett MH, Marangos PJ, Bloom SR, Polak JM: Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung. Histopathology 1984;8:171-181.
12. Bedrossian CW: Diagnostic problems in serous effusions. Diagn Cytopathol 1998;19:131-137.
13. Fetsch PA, Abati A: Immunocytochemistry in effusion cytology: a contemporary review. Cancer 2001;93:293-308.
14. Monte SA, Ehya H, Lang WR: Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987;31:448-452.
15. Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B: Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Am J Clin Pathol 2002;118:85-92.
16. Miller YE: Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 2005;33:216-223.
17. Motherby H, Pomjanski N, Kube M, Boros A, Heiden T, Tribukait B, Bocking A: Diagnostic DNA-flow- vs. -image-cytometry in effusion cytology. Anal Cell Pathol 2002;24:5-15.
18. Broers JL, Klein RM, de Leij L, Wagenaar SS, Carney DN, Vooijs GP, Ramaekers FC: Monoclonal antibodies in lung cancer pathology. Eur J Respir Dis Suppl 1987;149:11-18.
19. Postmus PE, Hirschler-Schulte TJ, de Leij L, Poppema S, Elema JE, Edens ET, Mesander G, Sluiter HJ, The TH: Diagnostic application of a monoclonal antibody against small cell lung cancer. Cancer 1986;57:60-63.
20. Latza Z, Niedobitek G, Schwartin R, Nekarda H, Stein H: BerEp4: new monoclonal antibody which distinguishes epithelia from mesothelia. Am J Clin Pathol 1990;43:21-29.
21. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J: Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001;93:68-72.
22. Moldenhauer G, Momburg F, Moller P, Schwartz R, Hammerling GJ: Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987;56:714-721.
23. Edwards PAW: Heterogenous expression of cell-surface antigens in normal epithelia and their tumors, revealed by monoclonal antibodies. Cancer 1985;51:149.
24. Nance KV, Silverman JF: Immunocytochemical panel for the identification of malignant cells in serous effusions. Am J Clin Pathol 1991;95:867-874.
25. Metzgeroth G, Kuhn C, Schultheis B, Hehlmann R, Hastka J: Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions. Cytopathology; accepted for publication.
26. Hastka J: Immunzytologie. Stuttgart, Schattauer, 1997.
27. Bepler G, Jaques G, Havemann K, Koehler A, Johnson BE, Gazdar AF: Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer. Cancer Res 1987;47:1883-1891.
28. Broers JL, Carney DN, de Ley L, Vooijs GP, Ramaekers FC: Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines. Proc Natl Acad Sci U S A 1985;82:4409-4413.
29. Broers JL, Carney DN, Klein RM, Schaart G, Lane EB, Vooijs GP, Ramaekers FC: Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci 1986;83:37-60.
30. Bohrer MH, Hastka J: [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers]. Pathologe 1991;12:21-23.
31. Springall DR, Lackie P, Levene MM, Marangos PJ, Polak JM: Immunostaining for neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung. J Pathol 1984;143:259-265.
32. Pujol JL, Simony J, Laurent JC, Richer G, Mary H, Bousquet J, Godard P, Michel FB: Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers. Cancer Res 1989;49:2797-2802.
33. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS: Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics 2006;26:41-57.
34. Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL: Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 1985;55:1303-1311.
35. Hage R, Elbers HR, Brutel de la Riviere A, van den Bosch JM: Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer. Chest 1998;114:1316-1320.